Tech Company Financing Transactions
Loto Biotech Platform Funding Round
Scientifica Venture Capital participated in a $700 thousand funding round for Loto Biotech Platform. The financing round closed on 6/30/2025.
Transaction Overview
Company Name
Announced On
6/30/2025
Transaction Type
Venture Equity
Amount
$700,000
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds to expand operations and its development efforts.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Undisclosed
L'Aquila, Undisclosed
Italy
L'Aquila, Undisclosed
Italy
Phone
Undisclosed
Website
Email Address
Overview
LOTO Biotech is an innovative biotech startup developing a proprietary AI-driven platform to design siRNA-based pro-drugs for rare genetic disorders, with a focus on autosomal dominant diseases. Mission: To accelerate the discovery of siRNA therapies for genetic diseases through a scalable, AI-powered platform.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Founder
Isabella Baldini
Founder
Mattia Capulli
Founder
Riccardo Paone
Browse more venture capital transactions:
Prev: 6/30/2025: Levelpath venture capital transaction
Next: 6/30/2025: Audos venture capital transaction
Share this article
News on VC Transactions
We do our best to document every notable VC transaction. VC investment data records reported here are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs